Clinical trial in Australia tests effectiveness of naloxone by nose vs. injection for opioid overdose
(JAMA Network) A randomized clinical trial in Australia tested whether a dose of naloxone administered through the nose was as effective as the same dose delivered by injection to reverse opioid overdose as measured by the need for a rescue dose delivered by injection 10 minutes after the initial treatment.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
More News: Australia Health | Clinical Trials | International Medicine & Public Health | Overdose | Science